Biotech

Oxis Acquires Pharma Company, Appoints New CEO

Biotech

Oxis International appoints new CEO and Chief Medical Officer as it completes acquisition of Georgetown Translational Pharmaceuticals.

Oxis International (OTCQB:OXIS) appoints new CEO and Chief Medical Officer as it completes acquisition of  Georgetown Translational Pharmaceuticals, which will add new management and a class of close-to-market Central Nervous Systems products.
As quoted in the press release:

Oxis has agreed to pay 33 percent of its outstanding shares to GTP to complete the transaction, which is expected to close on or before 90 days as per the agreement.
Dr. Clarence-Smith will become Chief Executive Officer of Oxis as part of the acquisition and will be appointed to the Oxis Board of Directors. Also joining the company’s executive management team as part of the merger will be a Chief Medical Officer (name to be disclosed upon closing), who was formerly Vice President and Chief Medical Officer and Medical Director, Oncology Clinical R&D of Pfizer, Inc. (PFE).
Anthony J. Cataldo, who has served as Chief Executive Officer of Oxis since July 2014, will become Executive Chairman of the company. Steven Weldon will continue as Chief Financial Officer.
Prior to founding GTP, Dr. Clarence-Smith co-founded Chase Pharmaceuticals Corporation in Washington D.C. and served as Chairman of the company’s Board from 2008 to 2014. Chase Pharmaceuticals was acquired by Allergan, PLC (AGN) in 2016.
Under the deal, Allergan agreed to pay $125 million upfront along with potential Regulatory and commercial milestones of up to $875 million to the shareholders of Chase.

Click here to read the full press release.

Source: www.accesswire.com

MARKETS

Markets
TSX20751.05-16.33
TSXV629.83+3.66
DOW34092.96+6.92
S&P 5004119.21+42.61
NASD11816.32+231.77
ASX7476.70-5.00

COMMODITIES

Commodities
Gold1950.13+22.82
Silver23.98+0.30
Copper4.18-0.05
Palladium1713.170.00
Platinum1087.260.00
Oil76.78-2.09
Heating Oil2.96-0.18
Natural Gas2.51-0.17

DOWNLOAD FREE REPORTS

×